Risk factors for chemotherapy-induced oral mucositis in cancer patients: a systematic review and meta-analysis

  • 0Nursing Department, Zhongshan Hospital, Xiamen University, Xiamen, 361004, China.

Summary

This summary is machine-generated.

Identifying risk factors for chemotherapy-induced oral mucositis (CIOM) is key. Poor oral hygiene, smoking, and specific chemotherapy regimens increase CIOM risk in cancer patients.

Area Of Science

  • Oncology
  • Evidence-based Medicine
  • Systematic Review

Background

  • Chemotherapy-induced oral mucositis (CIOM) is a common and debilitating side effect of cancer treatment.
  • Identifying modifiable and non-modifiable risk factors is crucial for effective prevention and management strategies.

Purpose Of The Study

  • To systematically review and meta-analyze the factors influencing the risk of chemotherapy-induced oral mucositis in cancer patients.
  • To identify key risk factors for CIOM through a comprehensive literature search and statistical analysis.

Main Methods

  • A systematic literature search was performed across multiple databases up to August 2024.
  • Meta-analysis was conducted using RevMan5.4 software to assess risk factors (Odds Ratios and 95% Confidence Intervals).
  • Study quality was evaluated using the Newcastle-Ottawa Scale and AHRQ criteria, with evidence grading by GRADEpro GDT.

Main Results

  • Ten studies involving 2365 cancer patients were included, with six high-quality and four moderate-quality studies.
  • Significant risk factors for CIOM included a history of oral disease, combination chemotherapy, smoking history, poor oral hygiene, and specific chemotherapy regimens (5-FU/methotrexate).

Conclusions

  • Several independent risk factors for chemotherapy-induced oral mucositis have been identified.
  • Early screening and prompt intervention for patients with identified risk factors are essential for reducing CIOM incidence and improving patient outcomes.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT<sub>3</sub> Receptor Antagonists 01:27

330

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...

Cancer Therapies 02:49

8.0K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists 01:28

267

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids 01:21

371

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists 01:29

461

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...

Cancer Prevention 02:59

6.3K

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...